#begin document (en_3757.txt); part 000
en_3757.txt	0	0	Should	MD	(TOP(SQ*	-	-	-	-	*	-
en_3757.txt	0	1	Children	NNP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	2	Take	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	Antidepressants	NNPS	(NP*))	-	-	-	-	*	-
en_3757.txt	0	4	?	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_3757.txt	0	1	last	JJ	*	-	-	-	-	*	-
en_3757.txt	0	2	12	CD	*	-	-	-	-	*	-
en_3757.txt	0	3	months	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	4	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	witnessed	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	6	radical	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	7	changes	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	8	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	9	considerable	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	10	controversy	NN	*)	-	-	-	-	*	-
en_3757.txt	0	11	regarding	VBG	(VP*	-	-	-	-	*	-
en_3757.txt	0	12	how	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_3757.txt	0	13	childhood	NN	(S(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	14	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	15	teenage	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	16	depression	NN	*))	-	-	-	-	*	-
en_3757.txt	0	17	is	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	18	treated	VBN	(VP*)))))))))	-	-	-	-	*	-
en_3757.txt	0	19	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Although	IN	(TOP(S(SBAR*	-	-	-	-	*	-
en_3757.txt	0	1	few	JJ	(S(NP*	-	-	-	-	*	(0
en_3757.txt	0	2	antidepressant	NN	*	-	-	-	-	*	-
en_3757.txt	0	3	drugs	NNS	*)	-	-	-	-	*	0)
en_3757.txt	0	4	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	6	licensed	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	7	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	8	pediatric	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	9	use	NN	*)))))))	-	-	-	-	*	-
en_3757.txt	0	10	,	,	*	-	-	-	-	*	-
en_3757.txt	0	11	rates	NNS	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	13	prescribing	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	15	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	16	under-18	JJ	*	-	-	-	-	*	-
en_3757.txt	0	17	age	NN	*	-	-	-	-	*	-
en_3757.txt	0	18	group	NN	*))))))	-	-	-	-	*	-
en_3757.txt	0	19	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	20	risen	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	21	by	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	22	around	RB	(NP(QP*	-	-	-	-	*	-
en_3757.txt	0	23	60	CD	*)	-	-	-	-	*	-
en_3757.txt	0	24	%	NN	*))	-	-	-	-	*	-
en_3757.txt	0	25	over	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	26	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	27	past	JJ	*	-	-	-	-	*	-
en_3757.txt	0	28	decade	NN	*))	-	-	-	-	*	-
en_3757.txt	0	29	,	,	*	-	-	-	-	*	-
en_3757.txt	0	30	with	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	31	over	IN	(NP(NP(QP*	-	-	-	-	*	-
en_3757.txt	0	32	a	DT	*	-	-	-	-	*	-
en_3757.txt	0	33	million	CD	*)	-	-	-	-	*	-
en_3757.txt	0	34	children	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	35	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	36	adolescents	NNS	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	37	receiving	VBG	(VP*	-	-	-	-	*	-
en_3757.txt	0	38	what	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_3757.txt	0	39	are	VBP	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	40	called	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	41	selective	JJ	(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	42	serotonin	NN	*	-	-	-	-	*	-
en_3757.txt	0	43	reuptake	NN	*	-	-	-	-	*	-
en_3757.txt	0	44	inhibitors	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	45	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_3757.txt	0	46	SSRI	NNP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	47	'	:	*	-	-	-	-	*	-
en_3757.txt	0	48	s	VBZ	(VP*)	-	-	-	-	*	-
en_3757.txt	0	49	-RRB-	-RRB-	*)))))))))))))	-	-	-	-	*	-
en_3757.txt	0	50	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Now	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	1	,	,	*	-	-	-	-	*	-
en_3757.txt	0	2	however	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	3	,	,	*	-	-	-	-	*	-
en_3757.txt	0	4	concerns	NNS	(NP(NP(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	5	over	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	6	these	DT	(NP(NP(NP*	-	-	-	-	*	(0
en_3757.txt	0	7	drugs	NNS	*	-	-	-	-	*	-
en_3757.txt	0	8	'	POS	*)	-	-	-	-	*	0)
en_3757.txt	0	9	safety	NN	*	-	-	-	-	*	-
en_3757.txt	0	10	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	11	side	NN	*	-	-	-	-	*	-
en_3757.txt	0	12	effects	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	14	children	NNS	(NP*	-	-	-	-	*	-
en_3757.txt	0	15	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	16	adolescents	NNS	*)))))	-	-	-	-	*	-
en_3757.txt	0	17	–	SYM	(X*))	-	-	-	-	*	-
en_3757.txt	0	18	including	VBG	(VP*	-	-	-	-	*	-
en_3757.txt	0	19	elevated	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	20	suicide	NN	*	-	-	-	-	*	-
en_3757.txt	0	21	rates	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	22	–	SYM	(X*)))	-	-	-	-	*	-
en_3757.txt	0	23	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	24	awakened	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	25	regulators	NNS	(NP*)	-	-	-	-	*	-
en_3757.txt	0	26	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	27	many	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	28	countries	NNS	*))))	-	-	-	-	*	-
en_3757.txt	0	29	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	After	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3757.txt	0	1	reviewing	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	2	all	DT	(NP*	-	-	-	-	*	(1
en_3757.txt	0	3	relevant	JJ	*	-	-	-	-	*	-
en_3757.txt	0	4	pediatric	JJ	*	-	-	-	-	*	-
en_3757.txt	0	5	trials	NNS	*))))	-	-	-	-	*	1)
en_3757.txt	0	6	,	,	*	-	-	-	-	*	-
en_3757.txt	0	7	the	DT	(NP(NP(NP*	-	-	-	-	*	(2
en_3757.txt	0	8	UK	NNP	*	-	-	-	-	*	-
en_3757.txt	0	9	'	POS	*)	-	-	-	-	*	-
en_3757.txt	0	10	s	PRP	*	-	-	-	-	*	-
en_3757.txt	0	11	Medinces	NNP	*	-	-	-	-	*	-
en_3757.txt	0	12	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	13	Heathcare	NNP	*	-	-	-	-	*	-
en_3757.txt	0	14	products	NNS	*	-	-	-	-	*	-
en_3757.txt	0	15	Regulatory	NNP	*	-	-	-	-	*	-
en_3757.txt	0	16	Agency	NNP	*)	-	-	-	-	*	-
en_3757.txt	0	17	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_3757.txt	0	18	MHRA	NNP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	19	-RRB-	-RRB-	*))	-	-	-	-	*	2)
en_3757.txt	0	20	advised	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	21	that	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_3757.txt	0	22	the	DT	(S(NP*	-	-	-	-	*	-
en_3757.txt	0	23	risks	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	24	outweighed	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	25	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	26	benefits	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	27	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	28	all	DT	(NP(NP(NP*	-	-	-	-	*	(3
en_3757.txt	0	29	SSRI	NNP	*	-	-	-	-	*	-
en_3757.txt	0	30	'	POS	*)	-	-	-	-	*	3)
en_3757.txt	0	31	s	NN	*)	-	-	-	-	*	-
en_3757.txt	0	32	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_3757.txt	0	33	except	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	34	fluoxetine	NN	(NP*))	-	-	-	-	*	-
en_3757.txt	0	35	-RRB-	-RRB-	*)))))))	-	-	-	-	*	-
en_3757.txt	0	36	,	,	*	-	-	-	-	*	-
en_3757.txt	0	37	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	38	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	39	these	DT	(S(NP*	-	-	-	-	*	-
en_3757.txt	0	40	products	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	41	should	MD	(VP*	-	-	-	-	*	-
en_3757.txt	0	42	not	RB	*	-	-	-	-	*	-
en_3757.txt	0	43	be	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	44	prescribed	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	45	as	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	46	new	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	47	therapy	NN	*)	-	-	-	-	*	-
en_3757.txt	0	48	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	49	patients	NNS	(NP*))))	-	-	-	-	*	-
en_3757.txt	0	50	under	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	51	18	CD	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	52	years	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	53	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	54	age	NN	(NP*))))	-	-	-	-	*	-
en_3757.txt	0	55	with	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	56	depressive	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	57	illness	NN	*)))))))))	-	-	-	-	*	-
en_3757.txt	0	58	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3757.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	2	first	JJ	*	-	-	-	-	*	-
en_3757.txt	0	3	time	NN	*))	-	-	-	-	*	-
en_3757.txt	0	4	,	,	*	-	-	-	-	*	-
en_3757.txt	0	5	the	DT	(NP*	-	-	-	-	*	(2
en_3757.txt	0	6	MHRA	NNP	*)	-	-	-	-	*	2)
en_3757.txt	0	7	made	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	8	public	JJ	(S(ADJP*)	-	-	-	-	*	-
en_3757.txt	0	9	a	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	10	summary	NN	*)	-	-	-	-	*	-
en_3757.txt	0	11	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	12	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	13	review	NN	*))	-	-	-	-	*	-
en_3757.txt	0	14	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	15	this	DT	(S(NP*	-	-	-	-	*	-
en_3757.txt	0	16	decision	NN	*)	-	-	-	-	*	-
en_3757.txt	0	17	was	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	18	based	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	19	on	IN	(PP*)	-	-	-	-	*	-
en_3757.txt	0	20	,	,	*	-	-	-	-	*	-
en_3757.txt	0	21	including	VBG	(PP*	-	-	-	-	*	-
en_3757.txt	0	22	both	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	23	efficacy	NN	*	-	-	-	-	*	-
en_3757.txt	0	24	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	25	safety	NN	*	-	-	-	-	*	-
en_3757.txt	0	26	data	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	27	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	28	all	DT	(NP(NP*)	-	-	-	-	*	(4
en_3757.txt	0	29	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	30	the	DT	(NP*	-	-	-	-	*	(1
en_3757.txt	0	31	trials	NNS	*))))))))))))	-	-	-	-	*	4)|1)
en_3757.txt	0	32	,	,	*	-	-	-	-	*	-
en_3757.txt	0	33	regardless	RB	(ADVP*	-	-	-	-	*	-
en_3757.txt	0	34	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	35	whether	IN	(SBAR(SBAR*	-	-	-	-	*	-
en_3757.txt	0	36	they	PRP	(S(NP*)	-	-	-	-	*	(4)
en_3757.txt	0	37	had	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	38	previously	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	39	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	40	published	VBN	(VP*)))))	-	-	-	-	*	-
en_3757.txt	0	41	or	CC	*	-	-	-	-	*	-
en_3757.txt	0	42	not	RB	*))))	-	-	-	-	*	-
en_3757.txt	0	43	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_3757.txt	0	1	was	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	2	important	JJ	(ADJP*)	-	-	-	-	*	-
en_3757.txt	0	3	because	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	4	about	IN	(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	5	half	NN	*)	-	-	-	-	*	-
en_3757.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	7	the	DT	(NP*	-	-	-	-	*	(1
en_3757.txt	0	8	trials	NNS	*)))	-	-	-	-	*	1)
en_3757.txt	0	9	had	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	10	not	RB	*	-	-	-	-	*	-
en_3757.txt	0	11	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	12	published	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	13	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	14	peer-reviewed	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	15	journals	NNS	*))))))))	-	-	-	-	*	-
en_3757.txt	0	16	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	(5
en_3757.txt	0	1	pediatric	JJ	*	-	-	-	-	*	-
en_3757.txt	0	2	trial	NN	*	-	-	-	-	*	-
en_3757.txt	0	3	data	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	4	released	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	by	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	6	the	DT	(NP*	-	-	-	-	*	(2
en_3757.txt	0	7	MHRA	NNP	*))))	-	-	-	-	*	5)|2)
en_3757.txt	0	8	presented	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	9	a	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	10	unique	JJ	*	-	-	-	-	*	-
en_3757.txt	0	11	opportunity	NN	*	-	-	-	-	*	-
en_3757.txt	0	12	to	TO	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	13	examine	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	14	whether	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	15	the	DT	(S(NP*	-	-	-	-	*	(5
en_3757.txt	0	16	unpublished	JJ	*	-	-	-	-	*	-
en_3757.txt	0	17	data	NNS	*)	-	-	-	-	*	5)
en_3757.txt	0	18	supported	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	19	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	20	findings	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	21	from	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	22	published	VBN	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	23	studies	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	24	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	25	SSRI	NNP	(NP(NP*	-	-	-	-	*	(3|(6
en_3757.txt	0	26	'	POS	*)	-	-	-	-	*	3)
en_3757.txt	0	27	s	NN	*))))))))))))	-	-	-	-	*	6)
en_3757.txt	0	28	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	My	PRP$	(TOP(S(NP(NP*	-	-	-	-	*	(7)
en_3757.txt	0	1	colleagues	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	2	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	3	I	PRP	(NP*))	-	-	-	-	*	(7)
en_3757.txt	0	4	addressed	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	this	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	6	question	NN	*)	-	-	-	-	*	-
en_3757.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	8	a	DT	(NP(NP*	-	-	-	-	*	(8
en_3757.txt	0	9	review	NN	*)	-	-	-	-	*	-
en_3757.txt	0	10	published	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	11	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	12	The	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	13	Lancet	NNP	*)))))	-	-	-	-	*	8)
en_3757.txt	0	14	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	15	April	NNP	(NP*	-	-	-	-	*	(9
en_3757.txt	0	16	2004	CD	*)))	-	-	-	-	*	9)
en_3757.txt	0	17	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(8
en_3757.txt	0	1	review	NN	*)	-	-	-	-	*	8)
en_3757.txt	0	2	showed	VBD	(VP(VP*	-	-	-	-	*	-
en_3757.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	4	while	IN	(S(SBAR*	-	-	-	-	*	-
en_3757.txt	0	5	the	DT	(S(NP*	-	-	-	-	*	-
en_3757.txt	0	6	published	VBN	*	-	-	-	-	*	-
en_3757.txt	0	7	data	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	8	generally	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	9	indicated	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	10	minimal	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	11	risk	NN	*))))	-	-	-	-	*	-
en_3757.txt	0	12	,	,	*	-	-	-	-	*	-
en_3757.txt	0	13	the	DT	(NP*	-	-	-	-	*	(5
en_3757.txt	0	14	unpublished	JJ	*	-	-	-	-	*	-
en_3757.txt	0	15	trial	NN	*	-	-	-	-	*	-
en_3757.txt	0	16	data	NN	*)	-	-	-	-	*	5)
en_3757.txt	0	17	were	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	18	far	RB	(ADJP*	-	-	-	-	*	-
en_3757.txt	0	19	less	RBR	*	-	-	-	-	*	-
en_3757.txt	0	20	sanguine	JJ	*)))))	-	-	-	-	*	-
en_3757.txt	0	21	,	,	*	-	-	-	-	*	-
en_3757.txt	0	22	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	23	even	RB	(VP(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	24	suggested	VBD	*	-	-	-	-	*	-
en_3757.txt	0	25	an	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	26	increased	JJ	*	-	-	-	-	*	-
en_3757.txt	0	27	risk	NN	*)	-	-	-	-	*	-
en_3757.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	29	serious	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	30	adverse	JJ	*	-	-	-	-	*	-
en_3757.txt	0	31	events	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	32	,	,	*	-	-	-	-	*	-
en_3757.txt	0	33	including	VBG	(PP*	-	-	-	-	*	-
en_3757.txt	0	34	suicide-related	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	35	behavior	NN	*)))))))	-	-	-	-	*	-
en_3757.txt	0	36	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	(2
en_3757.txt	0	1	MHRA	NNP	*)	-	-	-	-	*	2)
en_3757.txt	0	2	was	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	not	RB	*	-	-	-	-	*	-
en_3757.txt	0	4	alone	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	6	being	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	7	concerned	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	8	about	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	9	pediatric	JJ	(NP*	-	-	-	-	*	(10
en_3757.txt	0	10	trials	NNS	*)))))))	-	-	-	-	*	10)
en_3757.txt	0	11	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	A	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	1	review	NN	*)	-	-	-	-	*	-
en_3757.txt	0	2	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	4	British	NNP	*	-	-	-	-	*	-
en_3757.txt	0	5	Medical	NNP	*	-	-	-	-	*	-
en_3757.txt	0	6	Journal	NNP	*)	-	-	-	-	*	-
en_3757.txt	0	7	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_3757.txt	0	8	BMJ	NNP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	9	-RRB-	-RRB-	*)	-	-	-	-	*	-
en_3757.txt	0	10	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	11	April	NNP	(NP*	-	-	-	-	*	(9
en_3757.txt	0	12	2004	CD	*))	-	-	-	-	*	9)
en_3757.txt	0	13	,	,	*)))	-	-	-	-	*	-
en_3757.txt	0	14	claimed	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	15	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	16	most	JJS	(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	17	papers	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	18	on	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	19	SSRI	NNP	(NP*	-	-	-	-	*	(10
en_3757.txt	0	20	trials	NNS	*)))	-	-	-	-	*	10)
en_3757.txt	0	21	overstated	VBN	(VP(VP*	-	-	-	-	*	-
en_3757.txt	0	22	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	23	evidence	NN	*)	-	-	-	-	*	-
en_3757.txt	0	24	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	25	efficacy	NN	(NP*)))	-	-	-	-	*	-
en_3757.txt	0	26	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	27	understated	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	28	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	29	risk	NN	*)	-	-	-	-	*	-
en_3757.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	31	harm	NN	(NP*))))))))	-	-	-	-	*	-
en_3757.txt	0	32	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	An	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	1	article	NN	*)	-	-	-	-	*	-
en_3757.txt	0	2	by	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	4	Center	NNP	*)	-	-	-	-	*	-
en_3757.txt	0	5	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	6	Science	NNP	(NP*))	-	-	-	-	*	-
en_3757.txt	0	7	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	8	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	9	Public	NNP	*	-	-	-	-	*	-
en_3757.txt	0	10	Interest	NNP	*)))))	-	-	-	-	*	-
en_3757.txt	0	11	classified	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	12	all	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	13	available	JJ	*	-	-	-	-	*	-
en_3757.txt	0	14	published	VBN	*	-	-	-	-	*	-
en_3757.txt	0	15	placebo-controlled	JJ	*	-	-	-	-	*	-
en_3757.txt	0	16	trials	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	17	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	18	SSRI	NNP	(NP(NP*	-	-	-	-	*	(3|(6
en_3757.txt	0	19	'	POS	*)	-	-	-	-	*	3)
en_3757.txt	0	20	s	NN	*)))	-	-	-	-	*	6)
en_3757.txt	0	21	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	22	children	NNS	(NP*	-	-	-	-	*	-
en_3757.txt	0	23	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	24	adolescents	NNS	*))	-	-	-	-	*	-
en_3757.txt	0	25	as	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	26	industry-funded	JJ	(ADJP*	-	-	-	-	*	-
en_3757.txt	0	27	or	CC	*	-	-	-	-	*	-
en_3757.txt	0	28	non-industry	NN	(ADJP*	-	-	-	-	*	-
en_3757.txt	0	29	funded	JJ	*))))	-	-	-	-	*	-
en_3757.txt	0	30	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_3757.txt	0	1	results	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	2	showed	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	4	90	CD	(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	5	%	NN	*)	-	-	-	-	*	-
en_3757.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	7	industry-funded	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	8	trials	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	10	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	11	published	VBN	*	-	-	-	-	*	-
en_3757.txt	0	12	literature	NN	*)))))	-	-	-	-	*	-
en_3757.txt	0	13	were	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	14	reported	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	15	as	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	16	positive	JJ	(ADJP*))	-	-	-	-	*	-
en_3757.txt	0	17	,	,	*	-	-	-	-	*	-
en_3757.txt	0	18	while	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	19	only	RB	(S(NP(NP(QP*	-	-	-	-	*	-
en_3757.txt	0	20	55.6	CD	*)	-	-	-	-	*	-
en_3757.txt	0	21	%	NN	*)	-	-	-	-	*	-
en_3757.txt	0	22	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	23	non-industry-funded	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	24	trials	NNS	*)))	-	-	-	-	*	-
en_3757.txt	0	25	were	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	26	positive	JJ	(ADJP*)))))))))	-	-	-	-	*	-
en_3757.txt	0	27	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	More	RBR	(TOP(S(ADVP*	-	-	-	-	*	-
en_3757.txt	0	1	recently	RB	*)	-	-	-	-	*	-
en_3757.txt	0	2	,	,	*	-	-	-	-	*	-
en_3757.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	4	US	NNP	*	-	-	-	-	*	-
en_3757.txt	0	5	Food	NNP	*	-	-	-	-	*	-
en_3757.txt	0	6	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	7	Drug	NNP	*	-	-	-	-	*	-
en_3757.txt	0	8	Administration	NNP	*)	-	-	-	-	*	-
en_3757.txt	0	9	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_3757.txt	0	10	FDA	NNP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	11	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_3757.txt	0	12	applied	VBD	(VP(VP*	-	-	-	-	*	-
en_3757.txt	0	13	a	SYM	(NP*)	-	-	-	-	*	-
en_3757.txt	0	14	''	''	*	-	-	-	-	*	-
en_3757.txt	0	15	black	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	16	box	NN	*)	-	-	-	-	*	-
en_3757.txt	0	17	''	''	*	-	-	-	-	*	-
en_3757.txt	0	18	warning	VBG	(VP*	-	-	-	-	*	-
en_3757.txt	0	19	to	TO	(PP*	-	-	-	-	*	-
en_3757.txt	0	20	all	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	21	antidepressant	NN	*	-	-	-	-	*	-
en_3757.txt	0	22	drugs	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	23	labelling	VBG	(VP*))))))	-	-	-	-	*	-
en_3757.txt	0	24	,	,	*	-	-	-	-	*	-
en_3757.txt	0	25	but	CC	*	-	-	-	-	*	-
en_3757.txt	0	26	fell	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	27	short	RB	(ADVP*	-	-	-	-	*	-
en_3757.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	29	restricting	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	30	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	31	use	NN	*)	-	-	-	-	*	-
en_3757.txt	0	32	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	33	any	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	34	individual	JJ	*	-	-	-	-	*	-
en_3757.txt	0	35	drug	NN	*)))))))))	-	-	-	-	*	-
en_3757.txt	0	36	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_3757.txt	0	1	was	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	2	done	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	after	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	4	an	DT	(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	5	FDA	NNP	*	-	-	-	-	*	-
en_3757.txt	0	6	commissioned	VBN	*	-	-	-	-	*	-
en_3757.txt	0	7	re-analysis	NN	*)	-	-	-	-	*	-
en_3757.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	9	safety	NN	(NP*	-	-	-	-	*	-
en_3757.txt	0	10	data	NNS	*))	-	-	-	-	*	-
en_3757.txt	0	11	from	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	12	all	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	13	trials	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	15	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	16	newer	JJR	*	-	-	-	-	*	-
en_3757.txt	0	17	antidepressants	NNS	*)))))	-	-	-	-	*	-
en_3757.txt	0	18	demonstrated	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	19	increased	VBN	(NP(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	20	risk	NN	*)	-	-	-	-	*	-
en_3757.txt	0	21	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	22	suicidality	NN	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	23	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_3757.txt	0	24	definitive	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	25	suicidal	JJ	*	-	-	-	-	*	-
en_3757.txt	0	26	behaviour	NN	*	-	-	-	-	*	-
en_3757.txt	0	27	/	NN	*	-	-	-	-	*	-
en_3757.txt	0	28	ideation	NN	*)	-	-	-	-	*	-
en_3757.txt	0	29	-RRB-	-RRB-	*))))	-	-	-	-	*	-
en_3757.txt	0	30	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	31	increased	VBN	(NP(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	32	risk	NN	*)	-	-	-	-	*	-
en_3757.txt	0	33	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	34	treatment-emergent	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	35	hostility	NN	*)))	-	-	-	-	*	-
en_3757.txt	0	36	or	CC	*	-	-	-	-	*	-
en_3757.txt	0	37	agitation	NN	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	38	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	39	those	DT	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	40	treated	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	41	with	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	42	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	43	active	JJ	*	-	-	-	-	*	-
en_3757.txt	0	44	drug	NN	*))	-	-	-	-	*	-
en_3757.txt	0	45	compared	VBN	(PP*	-	-	-	-	*	-
en_3757.txt	0	46	to	TO	(PP*	-	-	-	-	*	-
en_3757.txt	0	47	placebo	NN	(NP*))))))))))))))	-	-	-	-	*	-
en_3757.txt	0	48	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Taken	VBN	(TOP(S(S(VP*	-	-	-	-	*	-
en_3757.txt	0	1	together	RB	(ADVP*)))	-	-	-	-	*	-
en_3757.txt	0	2	,	,	*	-	-	-	-	*	-
en_3757.txt	0	3	it	PRP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	4	is	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	not	RB	*	-	-	-	-	*	-
en_3757.txt	0	6	hard	JJ	(ADJP*)	-	-	-	-	*	-
en_3757.txt	0	7	to	TO	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	8	see	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	9	why	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_3757.txt	0	10	some	DT	(S(NP*	-	-	-	-	*	(11
en_3757.txt	0	11	commentators	NNS	*)	-	-	-	-	*	11)
en_3757.txt	0	12	argue	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	13	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	14	there	EX	(S(NP*)	-	-	-	-	*	-
en_3757.txt	0	15	has	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	16	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	17	little	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	18	attempt	NN	*)	-	-	-	-	*	-
en_3757.txt	0	19	by	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	20	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	21	pharmaceutical	JJ	*	-	-	-	-	*	-
en_3757.txt	0	22	industry	NN	*)))	-	-	-	-	*	-
en_3757.txt	0	23	to	TO	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	24	properly	RB	(VP(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	25	assess	VB	*	-	-	-	-	*	-
en_3757.txt	0	26	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	27	risks	NNS	*	-	-	-	-	*	-
en_3757.txt	0	28	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	29	benefits	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	31	their	PRP$	(NP*	-	-	-	-	*	(11)
en_3757.txt	0	32	products	NNS	*)))	-	-	-	-	*	-
en_3757.txt	0	33	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	34	under	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	35	18	CD	*))	-	-	-	-	*	-
en_3757.txt	0	36	'	''	*	-	-	-	-	*	-
en_3757.txt	0	37	s	PRP	(NP*)))))))))))))))	-	-	-	-	*	-
en_3757.txt	0	38	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Often	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	1	,	,	*	-	-	-	-	*	-
en_3757.txt	0	2	where	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_3757.txt	0	3	trials	NNS	(S(NP*)	-	-	-	-	*	-
en_3757.txt	0	4	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	6	conducted	VBN	(VP*)))))	-	-	-	-	*	-
en_3757.txt	0	7	,	,	*	-	-	-	-	*	-
en_3757.txt	0	8	only	RB	(NP*	-	-	-	-	*	-
en_3757.txt	0	9	favorable	JJ	*	-	-	-	-	*	-
en_3757.txt	0	10	results	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	11	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	12	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	13	published	VBN	(VP*)))	-	-	-	-	*	-
en_3757.txt	0	14	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_3757.txt	0	1	problem	NN	*)	-	-	-	-	*	-
en_3757.txt	0	2	is	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	widespread	JJ	(UCP(ADJP*)	-	-	-	-	*	-
en_3757.txt	0	4	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	5	not	RB	*	-	-	-	-	*	-
en_3757.txt	0	6	restricted	VBN	(ADJP*	-	-	-	-	*	-
en_3757.txt	0	7	to	TO	(PP*	-	-	-	-	*	-
en_3757.txt	0	8	drug	NN	(NP*	-	-	-	-	*	-
en_3757.txt	0	9	companies	NNS	*)))))	-	-	-	-	*	-
en_3757.txt	0	10	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Both	CC	(TOP(S*	-	-	-	-	*	-
en_3757.txt	0	1	regulators	NNS	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	2	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	3	clinicians	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	4	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_3757.txt	0	5	run	VBP	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	6	trials	NNS	(NP*)))))	-	-	-	-	*	-
en_3757.txt	0	7	have	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	8	been	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	9	criticized	VBN	(VP*)))	-	-	-	-	*	-
en_3757.txt	0	10	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Adding	VBG	(TOP(S(S(VP*	-	-	-	-	*	-
en_3757.txt	0	1	further	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	2	fuel	NN	*)	-	-	-	-	*	-
en_3757.txt	0	3	to	TO	(PP*	-	-	-	-	*	-
en_3757.txt	0	4	the	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	5	fire	NN	*))))	-	-	-	-	*	-
en_3757.txt	0	6	,	,	*	-	-	-	-	*	-
en_3757.txt	0	7	New	NNP	(NP*	-	-	-	-	*	-
en_3757.txt	0	8	York	NNP	*	-	-	-	-	*	-
en_3757.txt	0	9	State	NNP	*	-	-	-	-	*	-
en_3757.txt	0	10	Attorney	NNP	*	-	-	-	-	*	-
en_3757.txt	0	11	General	NNP	*	-	-	-	-	*	-
en_3757.txt	0	12	Eliot	NNP	*	-	-	-	-	*	-
en_3757.txt	0	13	Spitzer	NNP	*)	-	-	-	-	*	-
en_3757.txt	0	14	recently	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	15	filed	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	16	a	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	17	civil	JJ	*	-	-	-	-	*	-
en_3757.txt	0	18	lawsuit	NN	*)	-	-	-	-	*	-
en_3757.txt	0	19	against	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	20	GlaxoSmithKline	NNP	(NP*)))	-	-	-	-	*	(12)
en_3757.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	22	potentially	RB	(NP(ADJP*	-	-	-	-	*	-
en_3757.txt	0	23	misleading	JJ	*)	-	-	-	-	*	-
en_3757.txt	0	24	doctors	NNS	*))	-	-	-	-	*	-
en_3757.txt	0	25	by	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	26	publicizing	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	27	a	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	28	favorable	JJ	*	-	-	-	-	*	-
en_3757.txt	0	29	study	NN	*)	-	-	-	-	*	-
en_3757.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	31	paroxetine	NN	(NP*)))	-	-	-	-	*	-
en_3757.txt	0	32	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	33	pediatric	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	34	depression	NN	*))	-	-	-	-	*	-
en_3757.txt	0	35	while	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	36	downplaying	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	37	other	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	38	unfavorable	JJ	*	-	-	-	-	*	-
en_3757.txt	0	39	trials	NNS	*))))))))	-	-	-	-	*	-
en_3757.txt	0	40	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_3757.txt	0	1	response	NN	(NP*))	-	-	-	-	*	-
en_3757.txt	0	2	,	,	*	-	-	-	-	*	-
en_3757.txt	0	3	GlaxoSmithKline	NNP	(NP*)	-	-	-	-	*	(12)
en_3757.txt	0	4	made	VBD	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	full-trial	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	6	reports	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	8	all	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	9	studies	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	10	involving	VBG	(VP*	-	-	-	-	*	-
en_3757.txt	0	11	paroxetine	NN	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	13	patients	NNS	(NP(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	14	under	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	15	18	CD	(NP*)))	-	-	-	-	*	(13)
en_3757.txt	0	16	available	JJ	(ADJP*	-	-	-	-	*	-
en_3757.txt	0	17	on	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	18	their	PRP$	(NP*	-	-	-	-	*	(13)
en_3757.txt	0	19	website	NN	*)))))))))))	-	-	-	-	*	-
en_3757.txt	0	20	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_3757.txt	0	1	case	NN	*)	-	-	-	-	*	-
en_3757.txt	0	2	points	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	to	TO	(PP*	-	-	-	-	*	-
en_3757.txt	0	4	several	JJ	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	5	changes	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	8	way	NN	*)	-	-	-	-	*	-
en_3757.txt	0	9	data	NNS	(SBAR(S(NP*)	-	-	-	-	*	-
en_3757.txt	0	10	are	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	11	collected	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	12	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	13	released	VBN	*))))))	-	-	-	-	*	-
en_3757.txt	0	14	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3757.txt	0	15	are	VBP	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	16	urgently	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	17	needed	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	18	to	TO	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	19	determine	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	20	definitively	RB	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	21	whether	IN	*	-	-	-	-	*	-
en_3757.txt	0	22	SSRI	NNP	(S(NP(NP*	-	-	-	-	*	(3|(6
en_3757.txt	0	23	'	POS	*)	-	-	-	-	*	3)
en_3757.txt	0	24	s	NNS	*)	-	-	-	-	*	6)
en_3757.txt	0	25	are	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	26	safe	JJ	(ADJP*	-	-	-	-	*	-
en_3757.txt	0	27	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	28	effective	JJ	*	-	-	-	-	*	-
en_3757.txt	0	29	for	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	30	treating	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	31	pediatric	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	32	depression	NN	*))))))))))))))))))	-	-	-	-	*	-
en_3757.txt	0	33	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Tighter	NN	(TOP(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	1	regulation	NN	*)	-	-	-	-	*	-
en_3757.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	3	all	DT	(NP*	-	-	-	-	*	(14
en_3757.txt	0	4	clinical	JJ	*	-	-	-	-	*	-
en_3757.txt	0	5	trials	NNS	*)))	-	-	-	-	*	14)
en_3757.txt	0	6	is	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	7	needed	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	8	,	,	*	-	-	-	-	*	-
en_3757.txt	0	9	as	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	10	is	VBZ	(SINV(VP*)	-	-	-	-	*	-
en_3757.txt	0	11	a	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	12	public	JJ	*	-	-	-	-	*	-
en_3757.txt	0	13	worldwide	NN	*	-	-	-	-	*	-
en_3757.txt	0	14	database	NN	*)	-	-	-	-	*	-
en_3757.txt	0	15	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3757.txt	0	16	contains	VBZ	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	17	trial	NN	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	18	protocols	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	19	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	20	regularly	RB	(NP(NP(ADJP*	-	-	-	-	*	-
en_3757.txt	0	21	updated	VBN	*)	-	-	-	-	*	-
en_3757.txt	0	22	information	NN	*)	-	-	-	-	*	-
en_3757.txt	0	23	about	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	24	trial	NN	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	25	status	NN	*)	-	-	-	-	*	-
en_3757.txt	0	26	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	27	publications	NNS	(NP*)))))))))))))	-	-	-	-	*	-
en_3757.txt	0	28	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Moreover	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	1	,	,	*	-	-	-	-	*	-
en_3757.txt	0	2	both	DT	(S(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	3	benefits	NNS	*	-	-	-	-	*	-
en_3757.txt	0	4	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	5	harms	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	7	all	DT	(NP*	-	-	-	-	*	(14
en_3757.txt	0	8	trials	NNS	*)))	-	-	-	-	*	14)
en_3757.txt	0	9	must	MD	(VP*	-	-	-	-	*	-
en_3757.txt	0	10	be	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	11	published	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	12	within	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	13	a	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	14	reasonable	JJ	*	-	-	-	-	*	-
en_3757.txt	0	15	timeframe	NN	*))))))	-	-	-	-	*	-
en_3757.txt	0	16	,	,	*	-	-	-	-	*	-
en_3757.txt	0	17	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	18	properly	RB	(S(S(ADJP*	-	-	-	-	*	-
en_3757.txt	0	19	designed	VBN	*))	-	-	-	-	*	-
en_3757.txt	0	20	,	,	*	-	-	-	-	*	-
en_3757.txt	0	21	non-industry-funded	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	22	trials	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	23	are	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	24	needed	VBN	(VP*	-	-	-	-	*	-
en_3757.txt	0	25	to	TO	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	26	confirm	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	27	both	DT	(NP*	-	-	-	-	*	-
en_3757.txt	0	28	safety	NN	*	-	-	-	-	*	-
en_3757.txt	0	29	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	30	efficacy	NN	*)))))))	-	-	-	-	*	-
en_3757.txt	0	31	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Finally	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	1	,	,	*	-	-	-	-	*	-
en_3757.txt	0	2	product	NN	(NP*	-	-	-	-	*	-
en_3757.txt	0	3	labels	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	4	must	MD	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	reflect	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	6	negative	JJ	(NP(NP(ADJP*	-	-	-	-	*	-
en_3757.txt	0	7	or	CC	*	-	-	-	-	*	-
en_3757.txt	0	8	equivocal	JJ	*)	-	-	-	-	*	-
en_3757.txt	0	9	results	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	10	,	,	*	-	-	-	-	*	-
en_3757.txt	0	11	not	RB	(CONJP*	-	-	-	-	*	-
en_3757.txt	0	12	just	RB	*)	-	-	-	-	*	-
en_3757.txt	0	13	those	DT	(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	14	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_3757.txt	0	15	are	VBP	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	16	positive	JJ	(ADJP*))))))))	-	-	-	-	*	-
en_3757.txt	0	17	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	Such	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_3757.txt	0	1	changes	NNS	*)	-	-	-	-	*	-
en_3757.txt	0	2	may	MD	(VP*	-	-	-	-	*	-
en_3757.txt	0	3	well	RB	(ADVP*)	-	-	-	-	*	-
en_3757.txt	0	4	lead	VB	(VP*	-	-	-	-	*	-
en_3757.txt	0	5	to	TO	(PP*	-	-	-	-	*	-
en_3757.txt	0	6	a	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	7	dramatic	JJ	*	-	-	-	-	*	-
en_3757.txt	0	8	reduction	NN	*)	-	-	-	-	*	-
en_3757.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	10	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	11	use	NN	*)	-	-	-	-	*	-
en_3757.txt	0	12	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	13	SSRI	NNP	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	14	'	POS	*)	-	-	-	-	*	-
en_3757.txt	0	15	s	PRP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	16	in	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	17	treating	VBG	(S(VP*	-	-	-	-	*	-
en_3757.txt	0	18	depressed	JJ	(NP*	-	-	-	-	*	-
en_3757.txt	0	19	children	NNS	*	-	-	-	-	*	-
en_3757.txt	0	20	and	CC	*	-	-	-	-	*	-
en_3757.txt	0	21	adolescents	NNS	*))))))))))))	-	-	-	-	*	-
en_3757.txt	0	22	.	.	*))	-	-	-	-	*	-

en_3757.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_3757.txt	0	1	whatever	WDT	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	2	the	DT	(FRAG(NP*	-	-	-	-	*	-
en_3757.txt	0	3	outcome	NN	*)))	-	-	-	-	*	-
en_3757.txt	0	4	,	,	*	-	-	-	-	*	-
en_3757.txt	0	5	it	PRP	(NP*)	-	-	-	-	*	-
en_3757.txt	0	6	is	VBZ	(VP*	-	-	-	-	*	-
en_3757.txt	0	7	urgent	JJ	(ADJP*)	-	-	-	-	*	-
en_3757.txt	0	8	that	IN	(SBAR*	-	-	-	-	*	-
en_3757.txt	0	9	doubts	NNS	(S(NP(NP*)	-	-	-	-	*	-
en_3757.txt	0	10	about	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	11	the	DT	(NP(NP*	-	-	-	-	*	-
en_3757.txt	0	12	safety	NN	*)	-	-	-	-	*	-
en_3757.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_3757.txt	0	14	these	DT	(NP*	-	-	-	-	*	(0
en_3757.txt	0	15	drugs	NNS	*)))))	-	-	-	-	*	0)
en_3757.txt	0	16	are	VBP	(VP*	-	-	-	-	*	-
en_3757.txt	0	17	resolved	VBN	(VP*)))))	-	-	-	-	*	-
en_3757.txt	0	18	.	.	*))	-	-	-	-	*	-

#end document
